Arcellx, Inc. (ACLX)
68.34
-1.52
(-2.18%)
USD |
NASDAQ |
Jan 15, 16:00
68.40
+0.06
(+0.09%)
After-Hours: 20:00
Arcellx SG&A Expense (TTM): 110.28M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Gilead Sciences, Inc. | 5.886B |
| Johnson & Johnson | 23.38B |
| Amicus Therapeutics, Inc. | 353.07M |
| Relmada Therapeutics, Inc. | 28.04M |
| Invivyd, Inc. | 62.77M |